Nanoscience offers an excellent platform for developing nanotherapeutics and diagnostics, which is essential in the era of drug resistance. Researchers from Malaysia and Japan have published a review article in the Journal of Drug Delivery Science and Technology highlighting the use of nanomaterials/nanoformulations in the treatment of coronavirus infections. Nanomaterials are used in active and passive targeted therapies by inhibiting viral activity or preventing the virus from binding to the host cell receptors.
Nano-based formulation approaches have proven successful against previous coronaviruses in delivering the antigens and adjuvants, thereby preventing viral antigen agglomeration and improving the immune response against MERS-CoV. Over 283 candidate vaccines have been developed against SARS-COV-2, including vaccines with nanoencapsulated RNA or viral proteins. Key findings of…
